The market is becoming increasingly lucrative for women's health products, creating opportunities for market players. For instance, according to an NCBI article, the prevalence of menopausal symptoms and vulvovaginal atrophy ranges between 67% and 98% in Spanish women.
The increasing prevalence of targeted diseases and rising awareness among people are further boosting the market growth. For instance, according to the International Osteoporosis Foundation, the prevalence of osteoporosis is around 5.4% of the total population, out of these, around 79.2% of these are women patients.
Moreover, the number of fragility fractures in the country is expected to increase by more than 30% by 2034. Furthermore, according to World Bank, in 2022, Spain's women population aged 65 and above was around 5.46 million, which is further anticipated to increase the prevalence of targeted diseases.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account